🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objectives of the study were: 1. To assess the safety and tolerability...
Status
Completed
Location
Allergy, Asthma and Immunology Associates
Start Date
2009-08-31
Trial ID
NCT00914966
Treatments Being Tested
The purpose of this study is to evaluate safety, tolerability, immunogenici...
Status
Completed
Location
CMAX Clinical Research
Start Date
2020-12-30
Trial ID
NCT05490017
A new formulation of Berinert (CSL830) is being investigated for the manage...
Status
Completed
Location
Study Site
Start Date
2013-01
Trial ID
NCT01760343
This was a phase 1, first-in-human, single-center, randomized, double-blind...
Status
Completed
Location
Clinical Trial Site
Start Date
2017-11-28
Trial ID
NCT05047458
The main purpose of this study is to evaluate safety, tolerability, pharmac...
Status
Completed
Location
Nuvisan GmbH
Start Date
2021-08-03
Trial ID
NCT05018403
Treatments Being Tested
A Phase 2, Randomized, Placebo-controlled, Multicenter, Masked Study to Eva...
Status
Recruiting
Location
Associated Retina Consultants (01065)
Start Date
2025-06-23
Trial ID
NCT07215390
Treatments Being Tested
This is a platform trial to conduct a series of randomized, double-blind, p...
Status
Completed
Location
University of Alabama at Birmingham School of Medicine - Infectious Disease
Start Date
2021-08-03
Trial ID
NCT04988035
Treatments Being Tested
The goal of this clinical trial is to evaluate the safety and effectiveness...
Status
Recruiting
Location
Medical University of South Carolina
Start Date
2025-01-07
Trial ID
NCT06737380
Treatments Being Tested
CHAPLE syndrome (complement hyperactivation, angiopathic thrombosis, protei...
Status
Unknown
Location
Marmara University
Start Date
2018-06-15
Trial ID
NCT03950804
Treatments Being Tested
Oculgen has begun a study of an investigational drug called OCUL101 as a po...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04-17
Trial ID
NCT07520318
Treatments Being Tested